Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Tight Junction Protein Claudin-1 Is Differentially Expressed In Craniopharyngioma Subtypes And Indicates Invasive Tumor Growth.

C. Stache, A. Hoelsken, R. Fahlbusch, J. Flitsch, Sven-Martin Schlaffer, M. Buchfelder, R. Buslei
Published 2014 · Medicine, Biology

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Claudins are tight junction proteins expressed in epithelial tissues that play important roles in cell polarity and adhesion. Altered distribution of claudin-1(CLDN1) affects cell mobility and tumor invasiveness. Craniopharyngiomas (CPs) represent epithelial tumors of the sellar region, consisting of adamantinomatous (adaCP) and papillary (papCP) variants. Their tendency to infiltrate surrounding brain structures complicates successful surgery. Reliable markers are required to predict tumor behavior and to establish individualized treatment protocols. METHODS We describe the distribution pattern of CLDN1 in a large cohort of 66 adaCPs, 21 papCPs, and 24 Rathke`s cleft cyst (RCC) cases using immunohistochemistry. CLDN1 mRNA levels were analyzed with qRT-PCR in 33 CP samples. The impact on the migration potential was studied in primary adaCP cell cultures (n = 11) treated with small interfering RNA (siRNA) for CLDN1. Furthermore, CLDN1 distribution patterns and expression levels were compared between invasive (n = 16) and noninvasive (n = 17) tumor groups. RESULTS PapCPs and RCCs exhibited a distinct homogenous and membranous expression pattern, whereas CLDN1 immunoreactivity appeared weaker and more heterogeneous in adaCPs. In the latter cases, whirl-like cell clusters showed complete absence of CLDN1. mRNA analysis confirmed reduced CLDN1 levels in adaCPs versus papCPs. Interestingly, invasive tumors exhibited significantly lower CLDN1 expression compared with noninvasive counterparts regardless of CP subtype. Accordingly, siRNA treatment for CLDN1 altered tumor cell migration in vitro. CONCLUSION CLDN1 represents a novel marker in the differential diagnosis of CP variants and RCCs. Low CLDN1 expression levels correlate with an invasive CP growth pattern and may serve as a prognostic marker.
This paper references
10.3892/ijmm.2013.1348
Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression.
G. Zhang (2013)
10.1016/j.biocel.2010.06.019
Fascin: a key regulator of cytoskeletal dynamics.
A. Jayo (2010)
10.1158/0008-5472.CAN-05-4478
Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1.
N. Oku (2006)
10.1172/JCI24543
Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.
P. Dhawan (2005)
10.1007/s00381-005-1205-6
Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood
A. Pierre-Kahn (2005)
10.1007/s00018-006-6314-1
Claudins: multifunctional players in epithelial tight junctions and their role in cancer
S. S. Oliveira (2006)
10.1091/MBC.11.12.4131
Complex phenotype of mice lacking occludin, a component of tight junction strands.
M. Saitou (2000)
10.1016/0090-3019(83)90209-4
Symptomatic rathke's cleft cysts.
D. Rout (1983)
10.1371/journal.pone.0002715
Claudin-1 Is a p63 Target Gene with a Crucial Role in Epithelial Development
T. Lopardo (2008)
10.1158/0008-5472.CAN-05-2782
Claudin proteins in human cancer: promising new targets for diagnosis and therapy.
P. Morin (2005)
10.1158/1078-0432.CCR-10-2811
EGFR Signaling Regulates Tumor Cell Migration in Craniopharyngiomas
A. Hoelsken (2011)
10.1111/j.1750-3639.2008.00180.x
Target Gene Activation of the Wnt Signaling Pathway in Nuclear β‐Catenin Accumulating Cells of Adamantinomatous Craniopharyngiomas
A. Hoelsken (2009)
The histogenesis and histology of an integumentary type of epithelium in the human hypophysis. The Anatomical Record
Wm Shanklin (1951)
10.3389/fendo.2012.00080
Craniopharyngioma – A Childhood and Adult Disease with Challenging Characteristics
H. Müller (2012)
10.1007/BF01401137
Pathological characteristics of surgically removed craniopharyngiomas: Analysis of 131 cases
G. T. Szeifert (2005)
Role of CLDN1 in craniopharyngioma
Stache
10.1053/J.GASTRO.2004.07.022
Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease.
S. Hadj-Rabia (2004)
10.3171/2010.1.FOCUS09310
Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases.
S. Cavalheiro (2010)
10.1046/j.1365-2443.2003.00681.x
Expression and distribution of ZO‐3, a tight junction MAGUK protein, in mouse tissues
Akihito Inoko (2003)
10.1016/S0079-6107(02)00037-8
Tight junction proteins.
L. González-Mariscal (2003)
10.3171/JNS.1990.73.1.0012
Correlation of clinical and pathological features in surgically treated craniopharyngiomas.
T. E. Adamson (1990)
10.1002/AR.1091090206
The histogenesis and histology of an integumentary type of epithelium in the human hypophyses
W. Shanklin (1951)
10.3171/2010.1.FOCUS09315
Intracystic treatments for craniopharyngioma.
P. Steinbok (2010)
10.1097/00000478-200212000-00010
Expression of Claudin-1, a Recently Described Tight Junction-Associated Protein, Distinguishes Soft Tissue Perineurioma From Potential Mimics
A. Folpe (2002)
10.1083/jcb.200110122
Claudin-based tight junctions are crucial for the mammalian epidermal barrier
M. Furuse (2002)
10.3171/JNS.1966.24.1.0077
Intrasellar epithelial cysts.
C. Fager (1966)
10.1016/J.BBAMEM.2005.01.008
Epithelial transport and barrier function in occludin-deficient mice.
J. Schulzke (2005)
10.1016/j.bbcan.2011.04.001
Junctions gone bad: claudins and loss of the barrier in cancer.
K. Turksen (2011)
10.1055/S-2006-939854
[CranioNet -- an interdisciplinary strategy for craniopharyngioma].
K. Reschke (2006)
10.1097/00006123-199412000-00001
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.
H. Weiner (1994)
10.1053/j.gastro.2009.08.044
Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.
T. L. Chang (2010)
10.1007/s004390000375
Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer
Franziska Krämer (2000)
10.1007/s11102-005-0005-z
Symptomatic Rathke’s Cleft Cysts: A Radiological, Surgical and Pathological Review
D. Billeci (2005)
10.1073/pnas.1101553108
Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans
C. Gaston-Massuet (2011)
10.1186/bcr1265
Correction: Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study
A. Tőkés (2005)
10.1016/J.ADDR.2005.01.006
Role of claudins in tumorigenesis.
K. Swisshelm (2005)
10.1038/modpathol.3800301
Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study
M. Resnick (2005)
10.1148/RADIOL.2393050823
Intracranial cysts: radiologic-pathologic correlation and imaging approach.
A. Osborn (2006)
10.1007/s00401-006-0184-3
Nuclear β-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas
R. Buslei (2006)
10.1210/JCEM.82.7.4043
Clinical, radiological and pathological features of patients with Rathke's cleft cysts: tumors that may recur.
J. Mukherjee (1997)
10.3727/096504001108747477
Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers.
N. Miwa (2001)
10.3171/JNS.2004.100.1.0033
Surgical treatment of symptomatic Rathke cleft cysts: clinical features and results with special attention to recurrence.
J. E. Kim (2004)
10.1007/s00401-010-0642-9
Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling
A. Hoelsken (2010)
10.3171/JNS.1982.56.2.0290
Symptomatic Rathke's cleft cysts. Report of two cases.
G. Steinberg (1982)
10.1097/01.pas.0000155166.86409.d2
Soft Tissue Perineurioma: Clinicopathologic Analysis of 81 Cases Including Those With Atypical Histologic Features
J. Hornick (2005)
Craniopharyngiomas. Endocr Rev
N Karavitaki (2016)
10.1038/sj.onc.1210155
Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility
P. D. Leotlela (2007)
10.1097/01.pas.0000213328.64121.12
Nuclear β-Catenin Accumulation as Reliable Marker for the Differentiation Between Cystic Craniopharyngiomas and Rathke Cleft Cysts: A Clinico-Pathologic Approach
B. Hofmann (2006)
10.1016/j.bbrc.2009.01.124
Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cells.
Xiaoxiao Tian (2009)
10.1007/s00381-005-1209-2
Craniopharyngioma: the pendulum of surgical management
C. Sainte-Rose (2005)
10.1152/AJPCELL.1992.262.2.C461
Detection of the tight junction-associated protein ZO-1 in astrocytes and other nonepithelial cell types.
A. G. Howarth (1992)
Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas
R Buslei (2007)
10.1111/j.1399-6576.1995.tb04245.x
Report of two cases
K. Liu (1995)
10.1007/s00401-005-1004-x
Common mutations of β-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region
R. Buslei (2005)
10.1007/s00701-008-0137-9
Surgical management of giant craniopharyngiomas
R. Fahlbusch (2008)
10.1186/1471-2407-6-186
The claudin gene family: expression in normal and neoplastic tissues
K. J. Hewitt (2006)
The International Society for Pediatric Neurosurgery に参加して
稲垣 隆介 (2008)
10.3171/JNS.1994.80.6.1018
Epithelial cystic lesions of the sellar and parasellar region: a continuum of ectodermal derivatives?
M. Harrison (1994)
10.1309/G659FVVBMG7U4RPQ
Immunohistochemical staining for claudin-1 can help distinguish meningiomas from histologic mimics.
H. Hahn (2006)
10.1371/journal.pone.0037174
Caudal Homeobox Protein Cdx-2 Cooperates with Wnt Pathway to Regulate Claudin-1 Expression in Colon Cancer Cells
A. A. Bhat (2012)
10.5167/UZH-1853
MR differentiation of adamantinous and squamous-papillary craniopharyngiomas.
S. Sartoretti-Schefer (1997)
10.1083/JCB.121.3.491
The 220-kD protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction-associated protein in epithelial cells: cDNA cloning and immunoelectron microscopy
M. Itoh (1993)
10.1038/onc.2009.324
HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability
M. Krishnan (2010)
10.1111/j.1365-2265.2010.03838.x
Morbidity and mortality in patients with craniopharyngioma after surgery
R. Crowley (2010)
10.1111/j.1749-6632.2012.06613.x
Tight junctions on the move: molecular mechanisms for epithelial barrier regulation
L. Shen (2012)



This paper is referenced by
10.1186/s40478-016-0287-6
Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles
A. Hoelsken (2016)
10.4103/ijcep.ijcep_43_17
Potassium homeostasis, oxidative stress, and human disease
Udensi K. Udensi (2017)
10.1111/nan.12226
Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma
J. P. Martinez-Barbera (2015)
10.23937/2469-5807/1510094
Craniopharyngioma Brain Invasion Forms
Martha Lilia Tena-Suck (2019)
10.1111/bpa.12499
Models of human adamantinomatous craniopharyngioma tissue: Steps toward an effective adjuvant treatment
A. Hoelsken (2017)
10.1007/s00066-016-1014-8
Novel technique for high-precision stereotactic irradiation of mouse brains
J. Hartmann (2016)
University of Birmingham The medical therapy of craniopharyngiomas
K. Alexandraki (2019)
10.1515/jpem-2014-0442
Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models
J. P. Martinez-Barbera (2015)
10.1530/EJE-15-0957
ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.
P. Brastianos (2016)
10.1038/srep29731
EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke’s cleft cysts
V. Thimsen (2016)
10.1007/978-3-319-51890-9_1
Pathogenesis of Human ACP
A. Hoelsken (2017)
10.1021/acs.jproteome.5b00769
Systems Proteomics View of the Endogenous Human Claudin Protein Family.
F. Liu (2016)
10.1155/2019/3609789
Investigating the Protein Signature of Adamantinomatous Craniopharyngioma Pediatric Brain Tumor Tissue: Towards the Comprehension of Its Aggressive Behavior
C. Martelli (2019)
10.3171/2016.8.FOCUS16307
Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice.
J. Apps (2016)
10.1016/j.acthis.2015.09.006
Ultrastructural characterization of craniopharyngioma at the tumor boundary: A structural comparison with an experimental toxic model using "oil machinery" fluid, with emphasis on Rosenthal fibers.
M. Tena-Suck (2015)
10.1007/s11033-014-3543-5
The role of epithelial tight junctions involved in pathogen infections
Ru-Yi Lu (2014)
10.1007/978-3-030-41176-3
Adult Craniopharyngiomas: Differences and Lessons from Paediatrics
Emmanuel Jouanneau (2020)
10.3389/fgene.2018.00049
Rathke's Cleft Cyst as Origin of a Pediatric Papillary Craniopharyngioma
Sven-Martin Schlaffer (2018)
10.1007/978-3-319-22297-4_2
Craniopharyngioma: Pathological and Molecular Aspects
F. Roncaroli (2016)
10.1111/1759-7714.12368
Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
Bing-sheng Sun (2016)
10.4236/OJMN.2019.91008
Clinical, Pathological and Surgical Risk Factors Associated with Craniopharyngioma Recurrence: A Literature Review
James Lubuulwa (2019)
10.1111/bpa.12148
Insights into the Infiltrative Behavior of Adamantinomatous Craniopharyngioma in a New Xenotransplant Mouse Model
C. Stache (2015)
10.18632/oncotarget.18692
Gene expression profiling to predict recurrence of advanced squamous cell carcinoma of the tongue: discovery and external validation.
T. Enokida (2017)
10.4183/aeb.2020.103
Craniopharyngiomas in children - experience of consecutive 152 operated cases.
A. V. Ciurea (2020)
10.1007/978-3-030-11339-1_3
Adamantinomatous Craniopharyngioma: Genomics, Radiologic Findings, Clinical, and Prognosis
H. Müller (2019)
10.12688/f1000research.11549.1
Recent advances in molecular pathology of craniopharyngioma
Sarah J. Larkin (2017)
Recent advances in molecular pathology of craniopharyngioma [version 1; peer review: 2 approved]
Karavitaki (2019)
10.1007/s10143-018-1010-9
Craniopharyngioma adherence: a reappraisal of the evidence
R. Prieto (2018)
10.1038/nrendo.2016.217
New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma
H. Müller (2017)
10.1038/s41419-018-0732-5
The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis
Lin-lin Ren (2018)
10.1227/NEU.0000000000001408
Cystic Craniopharyngiomas: Microsurgical or Stereotactic Treatment?
W. Rachinger (2017)
10.1007/978-3-030-41176-3_11
Adult Versus Paediatric Craniopharyngiomas: Which Differences?
K. Sweeney (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar